Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Mar 11, 2021 10-K
8-K Mar 11, 2021 8-K
SC 13G/A Feb 16, 2021 SC 13G/A
SC 13G/A Feb 16, 2021
SC 13G/A Feb 12, 2021 SC 13G/A
8-K Jan 25, 2021 8-K
4 Jan 21, 2021 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
424B5 Jan 14, 2021 424B5
8-K Jan 14, 2021 8-K
424B5 Jan 13, 2021 424B5
4 Jan 11, 2021 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
8-K Jan 7, 2021 8-K
3 Dec 18, 2020 FORM 3 SUBMISSION
10-Q Nov 5, 2020 10-Q
8-K Nov 5, 2020 8-K
10-Q Aug 6, 2020 10-Q
8-K Aug 6, 2020 8-K
8-K Jul 14, 2020 8-K
4 Jul 13, 2020 FORM 4 SUBMISSION
SC 13G/A Jul 13, 2020 SC 13G/A
SC 13G/A Jul 10, 2020
8-K Jul 7, 2020 8-K
8-K Jun 12, 2020 8-K
4 Jun 11, 2020 FORM 4 SUBMISSION
4 Jun 11, 2020 FORM 4 SUBMISSION
← Newer Page 11 of 26 · 646 filings Older →